Septicemia, bacterial isolates and drug susceptibility among women attending delivery at dilchora hospital, dire dawa, Eastern Ethiopia

Background: Puerperal sepsis is the second most frequent cause of maternal morbidity and mortality in resource limited settings and often occurs within the first 42 days after childbirth. Objective: The aim of the study was to assess the prevalence of septicemia, its bacterial isolates, drug susceptibility patterns and associated factors among sepsis suspected women attending delivery at a referral hospital in Ethiopia. Method: A cross sectional study was conducted with a sample size of 441 women in the age group 15-49 years at Dilchora hospital, Dire Dawa, Eastern Ethiopia from May 1 to July 30, 2016. Sociodemographic and clinical data were collected using structured interview questionnaires. Blood was collected aseptically and inoculated into a broth medium and cultured aerobically for 48 hours. Antimicrobial susceptibility pattern of isolated bacteria was determined by Kirby Bauer disc diffusion method. Data were analyzed using SPSS version 16. Binary logistic regression was used to test for association. Significant variables were further adjusted using multivariate analysis. Result: The prevalence of septicemia was 12.9% of suspected cases and coagulase negative staphylococcus was found to be the most frequent isolate (28.1%) followed by E. coli (22.8%), Pseudomonas aeruginosa (10.5%) and Proteus spp (3.5%). Multiple vaginal examinations and multiple pregnancies were associated with the occurrence of sepsis. Conclusion: The prevalence of septicemia was 12.9%. Coagulase negative staphylococci and E. coli were the predominant bacteria isolated. Most of bacterial isolates were resistant against commonly used antibiotics such as ampicillin, amoxicillin and tetracycline

Seroprevalence of Hepatitis B virus surface antigen, anti-hepatitis C virus antibody and their associated factors among mothers living in Harar, Eastern Ethiopia

Background: Hepatitis B virus (HBV) and Hepatitis C Virus (HCV) infections are major causes of acute and chronic liver disease and infection by these viruses during pregnancy is associated with maternal, fetal and neonatal health complications. Understanding the epidemiology of these viruses could be valuable to take appropriate preventive measures. Objective: This study aims to determine the seroprevalence and associated factors of HBV and HCV infection among mothers living in Harar, Ethiopia. Materials and Methods: A cross-sectional study was conducted among 461 mothers living in Harar, Eastern Ethiopia from March 1 ­May 30, 2017. The systematic random sampling method was used to select the study participants. Sociodemographic information was collected through face-to-face interviews using pretested structured questionnaires. Five millilitres of venous blood was collected from each study subject and HBsAg and anti-HCV levels in sera were tested using a sandwich third generation Enzyme-Linked Immunosorbent Assay (ELISA). Data was analysed by using Statistical Package for Social Sciences (SPSS) version 20. Result: The seroprevalence rates for HBV and HCV infection were 5.9% and 1.1%, respectively. None of the mothers were co-infected with HBV and HCV. Among the potential risk factors, previous history of abortion (AOR =3.7 95%, CI 1.4-9.6) and multiple sexual exposures (AOR =10.6, 95% CI 4.0-27.9) were significant predictors of HBV infection. Conclusion: This study determined that the prevalence of HBV and HCV infection among mothers was 5.9% and 1.1% respectively. History of abortion and history of multiple sexual partners were significantly associated with HBV infection. Health education programs on the mode of HBV and HCV transmission, high-risk behaviours and methods of preventions are recommended to raise awareness and reduce the spread of infection

Serum level of anti-hepatitis B surface antigen and hbv associated factors among vaccinated and unvaccinated children in Harar, Eastern Ethiopia: a community - based study

Background: Hepatitis B virus infection is a major global health problem which is known to be the main cause of liver failure, cirrhosis, and hepatocellular carcinoma. Production of anti-HBs which is stimulated by HBV vaccine, provides protection against HBV infection. However, not all vaccinated children develop protective or durable levels of antibody against HBsAg. Therefore, testing for anti-HBs levels after HBV vaccination is important. Objective: The main objective of this study was to assess serum level of antibody against hepatitis B surface antigen among vaccinated and unvaccinated children in Harar, Eastern Ethiopia. Method: A community-based comparative cross-sectional study design was used. 540 children within the ages of 5-8 years (284 vaccinated and 256 unvaccinated) were enrolled in the study using simple random sampling in selected kebeles. Three to five milliliters of blood was collected from each study participant. Serum was separated and anti-HBsAg level was determined using ELISA. A pretested, structured questionnaire was used to collect socio-demographic and HBV associated factors exposure information of the study participants and their parents. Data entry and statistical analysis were done using SPSS statistical software version 21. Logistic regressions with 95% CI were used to identify independent predictors of anti-HBs. A p-value of less than 0.05 was considered statistically significant. Results: The overall seroprotection rate detected in this study was 95.4% among vaccinated children, whereas it was only 6.2% among unvaccinated children. 3.1% of unvaccinated children were positive for HBsAg, indicating chronic disease, whereas 1.1% of vaccinated children were HBsAg+. Anti-HBs levels declined from 414 U/ml at 5 years after vaccination to 105 U/ml after 8 years. Conclusion and Recommendation: Protective levels of anti-HBs were detected in 95.4% of vaccinated children suggesting that there is no need for a further booster dose for these children